patents.google.com

CN111588941A - Infusion port and method of use - Google Patents

  • ️Fri Aug 28 2020

CN111588941A - Infusion port and method of use - Google Patents

Infusion port and method of use Download PDF

Info

Publication number
CN111588941A
CN111588941A CN202010466767.9A CN202010466767A CN111588941A CN 111588941 A CN111588941 A CN 111588941A CN 202010466767 A CN202010466767 A CN 202010466767A CN 111588941 A CN111588941 A CN 111588941A Authority
CN
China
Prior art keywords
port
liquid storage
storage cavity
wall
bottom inner
Prior art date
2020-05-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010466767.9A
Other languages
Chinese (zh)
Inventor
尚小军
陈希明
钱丰
豆美娟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suzhou Linhwa Medical Devices Co ltd
Original Assignee
Suzhou Linhwa Medical Devices Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
2020-05-28
Filing date
2020-05-28
Publication date
2020-08-28
2020-05-28 Application filed by Suzhou Linhwa Medical Devices Co ltd filed Critical Suzhou Linhwa Medical Devices Co ltd
2020-05-28 Priority to CN202010466767.9A priority Critical patent/CN111588941A/en
2020-08-28 Publication of CN111588941A publication Critical patent/CN111588941A/en
Status Pending legal-status Critical Current

Links

  • 238000001802 infusion Methods 0.000 title claims abstract description 21
  • 238000000034 method Methods 0.000 title claims abstract description 12
  • 239000007788 liquid Substances 0.000 claims abstract description 46
  • 238000003860 storage Methods 0.000 claims abstract description 45
  • 238000002347 injection Methods 0.000 claims abstract description 27
  • 239000007924 injection Substances 0.000 claims abstract description 27
  • 239000013543 active substance Substances 0.000 claims abstract description 23
  • 239000012530 fluid Substances 0.000 claims description 9
  • 230000006378 damage Effects 0.000 claims description 5
  • 208000027418 Wounds and injury Diseases 0.000 claims description 4
  • 208000014674 injury Diseases 0.000 claims description 4
  • 230000000149 penetrating effect Effects 0.000 claims description 2
  • VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract description 3
  • 230000009286 beneficial effect Effects 0.000 abstract description 3
  • 239000000741 silica gel Substances 0.000 abstract description 3
  • 229910002027 silica gel Inorganic materials 0.000 abstract description 3
  • 230000000472 traumatic effect Effects 0.000 abstract description 2
  • 206010033675 panniculitis Diseases 0.000 description 7
  • 210000004304 subcutaneous tissue Anatomy 0.000 description 7
  • 238000004891 communication Methods 0.000 description 4
  • 239000008280 blood Substances 0.000 description 3
  • 210000004369 blood Anatomy 0.000 description 3
  • 230000000694 effects Effects 0.000 description 3
  • 238000010586 diagram Methods 0.000 description 2
  • 239000003814 drug Substances 0.000 description 2
  • 239000012528 membrane Substances 0.000 description 2
  • 239000000243 solution Substances 0.000 description 2
  • 230000002411 adverse Effects 0.000 description 1
  • 210000001367 artery Anatomy 0.000 description 1
  • 230000005540 biological transmission Effects 0.000 description 1
  • 239000010836 blood and blood product Substances 0.000 description 1
  • 229940125691 blood product Drugs 0.000 description 1
  • 238000010241 blood sampling Methods 0.000 description 1
  • 230000007547 defect Effects 0.000 description 1
  • 201000010099 disease Diseases 0.000 description 1
  • 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
  • 229940079593 drug Drugs 0.000 description 1
  • 238000002513 implantation Methods 0.000 description 1
  • 208000015181 infectious disease Diseases 0.000 description 1
  • 230000001788 irregular Effects 0.000 description 1
  • 230000000302 ischemic effect Effects 0.000 description 1
  • 238000004519 manufacturing process Methods 0.000 description 1
  • 238000012986 modification Methods 0.000 description 1
  • 230000004048 modification Effects 0.000 description 1
  • 230000017074 necrotic cell death Effects 0.000 description 1
  • 235000015097 nutrients Nutrition 0.000 description 1
  • 208000001297 phlebitis Diseases 0.000 description 1
  • 230000002980 postoperative effect Effects 0.000 description 1
  • 238000007789 sealing Methods 0.000 description 1
  • 230000035807 sensation Effects 0.000 description 1
  • 230000036558 skin tension Effects 0.000 description 1
  • 238000009987 spinning Methods 0.000 description 1
  • 239000000126 substance Substances 0.000 description 1
  • 230000007704 transition Effects 0.000 description 1
  • 210000003462 vein Anatomy 0.000 description 1

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/158Needles for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/158Needles for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body
    • A61M2005/1581Right-angle needle-type devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/158Needles for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body
    • A61M2005/1586Holding accessories for holding infusion needles on the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/158Needles for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body
    • A61M2005/1587Needles for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body suitable for being connected to an infusion line after insertion into a patient

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

The invention discloses an infusion port, which comprises a port body, a liquid storage cavity arranged in the port body, a connecting pipe used for fixing a catheter and the port body, and an injection piece fixedly arranged on the port body, wherein the plane of the lowest edge of the liquid storage cavity is always higher than or equal to the lowest point of the catheter, and the liquid storage cavity and the catheter have a height difference h, wherein h is more than or equal to 0. The invention has the following beneficial effects: because the height difference exists between the bottom inner wall of the port body and the lowest point of the conduit, the direct flow is ensured in the infusion process, and the medical active substance can not remain in the liquid storage cavity; and the liquid storage cavity and the silica gel are obliquely arranged and matched with the linear type non-traumatic needle, so that the operation and the use of medical personnel are facilitated.

Description

Infusion port and method of use

Technical Field

The invention relates to the technical field of medical articles, in particular to an infusion port and a using method thereof.

Background

The port is generally used for medical infusion and is used in cooperation with a non-invasive needle, and medical liquid is infused into the body of a patient through the non-invasive needle and the port to treat diseases of the patient. The structure of the transfusion port is more general, which is disclosed in US patent No. US4723948, US patent No. US4861341, US patent No. US5281205, US patent No. US9017300, Chinese patent No. CN105163795B, the general structure of which is shown in figure 1, comprising a

transfusion port body

101; a

reservoir

102 for containing a medically active substance; a connecting

tube

103 for connecting the conduits to establish a flow connection between the reservoir and the

conduit

104. The

port body

101 is provided with an

injection piece

105 at the top for piercing with an

atraumatic needle

106 and entering into the

reservoir

102. The

atraumatic needle

106 is typically a 90 ° right angle infusion needle.

Such a port can be implanted in a patient as is known from European patent EP1675641B1 by introducing the port, for example, under the skin (subcutaneous tissue) of the patient and fixing it there. The port is then used for introducing drugs, blood products, nutrients or other medically active substances into the venous or arterial system of a patient, by means of which the active substances can be administered to the patient in particular repeatedly over a longer period of time. Since the port can be completely implanted under the skin of the patient, the risk of infection is reduced, and the active substance can be specifically administered over a longer period of time for treating the patient, without the patient having to be hospitalized for this purpose and without the port obviously obstructing the patient in daily life.

During infusion, the active substance is removed from the

reservoir

102 of the

port body

101 via a

line

104 connected to a

connection tube

103 of the port and is delivered to the patient (for example, a vein or artery of the patient). The catheter is here implanted together with the port into the patient and laid such that the active substance is transported to a predetermined location in the patient. However, as shown in FIG. 1, the

opening

107 through the

port body

101 communicating with the

conduit

104 is typically at a higher elevation than the bottom of the

reservoir

102 so that when administering an infusion, the

active substance level

108 needs to be higher than the

opening

107 in order for the active substance to flow through the

opening

107 and into the

conduit

104. When one infusion is completed, there is a big problem that active substances remain in the

reservoir

102 at a space lower than the

opening

107, and the substances may contaminate the active substances in the next infusion after being left in the

reservoir

102 for a long time. This is not allowed. More likely, the port also exists as a blood sampling device, i.e., blood is returned from the

catheter

104 to the

reservoir

102 and drawn out of the body by the

atraumatic needle

106 with a negative pressure effect. After the blood drawing is completed, the blood may remain in the

reservoir chamber

102 at a position lower than the

opening

107, which is not allowed.

More specifically, the right-angle puncture of the atraumatic needle is different from the puncture mode of a common infusion needle, so that firstly, the manufacturing process is complex, and secondly, the operation of a medical care user is inconvenient. In addition, during practical use, the effective length of the needle tube needs to be selected by comprehensively considering the depth of the injection port body implanted into subcutaneous tissue, the thickness of an injection piece, the height of a liquid storage cavity of the injection port and other factors, is too short (a needle point hole does not completely support the liquid storage cavity and can cause liquid medicine to leak) and too long (the needle point penetrates the bottom surface of the liquid storage cavity to damage the needle point and the skin of the puncture point cannot be completely attached and fixed with the needle base), and can cause adverse effects.

Disclosure of Invention

The invention aims to overcome the defects in the prior art and provides an infusion port and a using method thereof.

The purpose of the invention is realized by the following technical scheme:

an infusion port comprises

A port body;

a reservoir disposed within the port for containing a medically active substance;

a connecting tube for securing the catheter and the port body so as to establish fluid communication between the reservoir and the catheter;

the injection piece is fixedly arranged on the harbor body and is used for the atraumatic needle to puncture and enter the liquid storage cavity;

the plane of the lowest edge of the liquid storage cavity is always higher than or equal to the lowest point of the guide pipe, and the liquid storage cavity and the guide pipe have a height difference h which is more than or equal to 0.

Preferably, the lowest edge of the reservoir chamber is the bottom inner wall of the harbor body, and the bottom inner wall is a plane.

Preferably, the harbor body further comprises a bottom outer wall having a cross-sectional profile conforming to the cross-sectional profile of the bottom inner wall.

Preferably, the reservoir chamber has a first port and a second port, the minimum aperture of the first port is larger than the maximum aperture of the second port, the syringe is fixed in the first port, and the conduit is communicated with the second port.

Preferably, the first port is arranged obliquely, the plane where the first port is located and the plane where the lowest edge is located form an included angle alpha, and alpha is larger than 0 degree and smaller than 90 degrees.

Preferably, the port body has an extension pipe, and the connection pipe is fitted around the extension pipe to fix the guide pipe thereto.

Preferably, the bottom inner wall of the extension tube is an extension of the bottom inner wall of the harbor body.

The invention also discloses a transfusion port, which comprises

A port body;

a reservoir disposed within the port for containing a medically active substance;

a connecting tube for securing the catheter and the port body so as to establish fluid communication between the reservoir and the catheter;

the injection piece is fixedly arranged on the harbor body and is used for the atraumatic needle to puncture and enter the liquid storage cavity;

the liquid storage cavity comprises a bottom inner wall, the flowing connection between the bottom inner wall and the guide pipe has a height difference h, and h is more than or equal to 0.

Preferably, the bottom inner wall has at least one flat surface.

Preferably, the cross section of the liquid storage cavity is a semi-hollow circle, a 3/4 hollow circle, a hollow circle or a hollow ellipse.

Preferably, the reservoir chamber has a first port and a second port, the minimum aperture of the first port is larger than the maximum aperture of the second port, the syringe is fixed in the first port, and the conduit is communicated with the second port.

Preferably, the first port is arranged obliquely, the plane where the first port is located and the plane where the lowest edge is located form an included angle alpha, and alpha is larger than 0 degree and smaller than 90 degrees.

Preferably, the port body has an extension pipe, and the connection pipe is fitted around the extension pipe to fix the guide pipe thereto.

The invention also discloses a transfusion port, which comprises

A port body;

a reservoir disposed within the port for containing a medically active substance;

a connecting tube for securing the catheter and the port body so as to establish fluid communication between the reservoir and the catheter;

the injection piece is fixedly arranged on the harbor body and is used for the atraumatic needle to puncture and enter the liquid storage cavity;

the harbor body comprises a bottom inner wall, and a height difference h is formed between the bottom inner wall and the lowest point of the conduit, wherein h is more than or equal to 0.

Preferably, the harbor body further comprises a bottom outer wall having a cross-sectional profile conforming to the cross-sectional profile of the bottom inner wall.

Preferably, the bottom inner wall is at least partially planar.

Preferably, the reservoir chamber has a first port and a second port, the minimum aperture of the first port is larger than the maximum aperture of the second port, the syringe is fixed in the first port, and the conduit is communicated with the second port.

Preferably, the first port is arranged obliquely, the plane where the first port is located and the plane where the lowest edge is located form an included angle alpha, and alpha is larger than 0 degree and smaller than 90 degrees.

The invention also discloses a using method of the transfusion port, which comprises the steps of,

configuring a port, the port comprising

A port body;

a reservoir disposed within the port for containing a medically active substance;

a connecting tube for securing the catheter and the port body so as to establish fluid communication between the reservoir and the catheter;

the injection piece is fixedly arranged on the harbor body and is used for the atraumatic needle to puncture and enter the liquid storage cavity;

the plane of the lowest edge of the liquid storage cavity is always higher than or equal to the lowest point of the guide pipe, the liquid storage cavity and the guide pipe have a height difference h, and h is more than or equal to 0;

a non-invasive needle is configured, and the needle body of the non-invasive needle is linear;

and (3) penetrating the needle body of the atraumatic needle through the injection piece and inserting the atraumatic needle into the liquid storage cavity of the transfusion port.

The invention has the following beneficial effects: because the height difference exists between the bottom inner wall of the port body and the lowest point of the conduit, the direct flow is ensured in the infusion process, and the medical active substance can not remain in the liquid storage cavity; and the liquid storage cavity and the silica gel are obliquely arranged and matched with the linear type non-traumatic needle, so that the operation and the use of medical personnel are facilitated.

Drawings

The technical scheme of the invention is further explained by combining the accompanying drawings as follows:

FIG. 1: is a structural schematic diagram of a transfusion port and a non-invasive needle matched with the transfusion port in the prior art;

FIG. 2: is a schematic structural view of a preferred embodiment of the port of the invention;

fig. 3 a-3 d: is a cross-sectional view taken along a-a in fig. 2, showing four structures, respectively;

FIG. 4: the invention is a schematic use diagram of the transfusion port.

Detailed Description

The present invention will be described in detail below with reference to specific embodiments shown in the drawings. These embodiments are not intended to limit the present invention, and structural, methodical, or functional changes that may be made by one of ordinary skill in the art in light of these embodiments are intended to be within the scope of the present invention.

In the description of the present invention, it is to be understood that the terms "center", "longitudinal", "lateral", "up", "down", "front", "back", "left", "right", "vertical", "horizontal", "top", "bottom", "inner", "outer", and the like, indicate orientations or positional relationships based on those shown in the drawings, and are used only for convenience in describing the present invention and for simplicity in description, and do not indicate or imply that the referenced devices or elements must have a particular orientation, be constructed and operated in a particular orientation, and thus, are not to be construed as limiting the present invention. Furthermore, the terms "first", "second", etc. are used for descriptive purposes only and are not to be construed as indicating or implying relative importance or implicitly indicating the number of technical features indicated. Thus, a feature defined as "first," "second," etc. may explicitly or implicitly include one or more of that feature. In the description of the present invention, "a plurality" means two or more unless otherwise specified.

In the description of the present invention, it should be noted that, unless otherwise explicitly specified or limited, the terms "mounted," "connected," and "connected" are to be construed broadly, e.g., as meaning either a fixed connection, a removable connection, or an integral connection; can be mechanically or electrically connected; they may be connected directly or indirectly through intervening media, or they may be interconnected between two elements. The specific meaning of the above terms in the present invention can be understood by those of ordinary skill in the art through specific situations.

The present invention will be described in detail below with reference to the embodiments with reference to the attached drawings.

As shown in fig. 2 to 4, the present invention discloses an infusion port, which comprises, similar to the prior art:

a port body 1;

a

reservoir

2 disposed within the port body 1 for containing a medically active substance; liquid storage herein means that there is partial storage of the medical active substance in the cavity during infusion;

a connecting

tube

3 for fixing the catheter 4 and the port body 1 so as to establish a fluid connection between the

reservoir

2 and the catheter 4;

and the

injection piece

5 is fixedly arranged on the port body 1 and is used for puncturing the

atraumatic needle

6 and entering the

liquid storage cavity

2. The injection member is typically a self-sealing membrane through which the

atraumatic needle

6 passes to communicate with the connector. The membrane is generally made of silica gel.

It should be understood by those skilled in the art that although the technical names of the present invention are the same as those of the prior art, the structure thereof is different from that of the prior art, and the following detailed description is made.

Referring specifically to fig. 2, the harbor body 1 comprises a bottom

outer wall

10, the lowest edge of the

reservoir chamber

2 is the bottom

inner wall

7 of the harbor body 1, and the cross-sectional profile of the bottom

outer wall

10 is identical to the cross-sectional profile of the bottom

inner wall

7.

The

liquid storage cavity

2 is provided with a

first port

8 and a second port 9, the minimum caliber of the

first port

8 is larger than the maximum caliber of the second port 9, and smooth transition is formed from the

first port

8 to the second port 9, namely the liquid storage cavity is in an irregular bell-mouth shape. The

injection member

5 is fixed in the

first port

8, and the conduit 4 is communicated with the second port 9.

As shown in fig. 2, the

first port

8 is disposed obliquely so that the axial section of the

reservoir

2 is triangular. The plane of the

first port

8 and the plane of the lowest edge of the

liquid storage cavity

2 form an included angle alpha, and alpha is more than 0 degree and less than 90 degrees.

In the preferred embodiment, the

first port

8 and the

injection member

5 are parallel to each other, i.e. the inclination angle of the

injection member

5 is the same as the inclination angle of the

first port

8, and of course, the skilled technician will be able to consider various considerations and the inclination angle of the

injection member

5 and the inclination angle of the

first port

8 may be different. Most importantly, the lowest point of the

first port

8 and the

syringe

5 is almost the same height as the lowest edge of the

reservoir

2, ensuring that the port body of the implanted port can be kept at the lowest height.

The definition of the cross-section of the

reservoir

2 according to the invention can be seen in connection with fig. 3a to 3 d.

In particular, the skilled person will be able to set the cross-section of the

reservoir

2 to be semi-hollow circular, 3/4 hollow circular, hollow oval or other, based on various considerations. One skilled in the art should be aware of: in order to prevent the port body from rotating or unnecessarily shaking after the subcutaneous tissue is implanted into the transfusion port, two sides of the port body 1 can be provided with flat side wings or an encapsulated block structure (not shown in the figure), and the side wings can also be provided with suture holes so that medical staff can fix the transfusion port during operation.

As shown in fig. 3a and 3b, the cross section of the

reservoir

2 is a semi-hollow circle, 3/4 hollow circle, the bottom

inner wall

7 has at least one

plane

12, and the

plane

12 is the plane of the lowest edge of the

reservoir

2; if the cross section of the

reservoir

2 disclosed in fig. 3c and 3d is a hollow circle or a hollow ellipse, the plane of the lowest point is the plane of the lowest edge of the

reservoir

2.

As can be seen from the figure 2, the plane of the lowest edge of the

liquid storage cavity

2 is always higher than or equal to the lowest point of the conduit 4, and the two have a height difference h which is more than or equal to 0, namely, during transfusion, the medical active substance can directly flow into the conduit 4 from the

liquid storage cavity

2, and no residue is generated in the

liquid storage cavity

2.

It should be noted that the lowest edge is not compared with the ground, but is the lowest edge located at the deepest part of the patient after being implanted into the subcutaneous tissue of the patient.

The harbor body 1 has an

extension pipe

11, and the

connection pipe

3 is fitted around the outer periphery of the

extension pipe

11 to fix the guide pipe 4 thereto. The bottom inner wall of the

extension tube

11 is an extension of the bottom

inner wall

7 of the harbor body 1. The

extension tube

11 is only used for connecting the catheter 4 and the harbor body 1, so the length and the thickness of the

extension tube

11 are not considered in the invention, and the specific connection mode can be a connection mode commonly used by technicians in the field such as spinning and buckling, and the like, and the detailed description is not repeated in the invention.

In the preferred embodiment of the invention it is disclosed that the flow connection between the bottom

inner wall

7 and the conduit 4 has a height difference h, h ≧ 0. The skilled person will be able to base various considerations on the fact that, in addition to the fact that the bottom edge of the axial cross section of the bottom

inner wall

7 is substantially parallel to the bottom edge of the axial cross section of the catheter 4 as disclosed in fig. 2, the bottom edge of the axial cross section of the bottom

inner wall

7 may also be at an angle with the bottom edge of the axial cross section of the catheter 4, that is, the bottom edge of the axial cross section of the bottom

inner wall

7 is inclined from the

first port

8 to the second port 9, so as to generate the effect of gradual closing up, and further facilitate the transmission of the medical active.

In the preferred embodiment of the invention, the height difference h between the bottom

inner wall

7 and the lowest point of the conduit 4 is also disclosed, and h is more than or equal to 0. The skilled person will be able to base various considerations on the fact that, in addition to the fact that the

bottom wall

7 is shown in fig. 2 as a smooth surface, it is also possible to provide a special surface with flow channels, for example a groove, with a height difference h between the lowest point of the groove and the lowest point of the conduit 4, h ≧ 0.

The invention also discloses a using method of the implantable transfusion port, which comprises the following steps:

providing an infusion port having the structure set forth above;

a

non-injury needle

6 is configured, and the needle body of the

non-injury needle

6 is linear;

as shown in FIG. 4, the port is placed under the

subcutaneous tissue

13 with some or all of the

injection member

5 in contact with the subcutaneous tissue. The body of the

atraumatic needle

6 is inserted into the

reservoir

2 of the port through the oblique subcutaneous tissue and the

oblique injection piece

5.

The

first port

8 and the

injection member

5 are arranged obliquely, which greatly reduces the overall height of the port at the site of implantation, reduces the pulling force of the port on the skin of the patient and reduces the pain and foreign body sensation of the patient.

The invention is matched with a linear type non-invasive needle, is beneficial to the operation and use of medical personnel, improves the effective area utilization rate of a puncture window, reduces the complexity of the operation and reduces the incidence rate of postoperative mechanical phlebitis; reduces the incidence of ischemic necrosis caused by skin tension loss after operation.

It should be understood that although the present description refers to embodiments, not every embodiment contains only a single technical solution, and such description is for clarity only, and those skilled in the art should make the description as a whole, and the technical solutions in the embodiments can also be combined appropriately to form other embodiments understood by those skilled in the art.

The above-listed detailed description is only a specific description of a possible embodiment of the present invention, and they are not intended to limit the scope of the present invention, and equivalent embodiments or modifications made without departing from the technical spirit of the present invention should be included in the scope of the present invention.

Claims (19)

1. An infusion port comprises

A port body (1);

a reservoir (2) arranged in the port body (1) for containing a medically active substance;

-a connecting tube (3) for fixing the catheter (4) and the port body (1) so as to establish a fluid connection between the reservoir (2) and the catheter (4);

the injection piece (5) is fixedly arranged on the harbor body (1) and is used for puncturing the atraumatic needle (6) and entering the liquid storage cavity (2);

the method is characterized in that:

the plane of the lowest edge of the liquid storage cavity (2) is always higher than or equal to the lowest point of the guide pipe (4), and the liquid storage cavity and the guide pipe have a height difference h which is more than or equal to 0.

2. The port of claim 1, wherein: the lowest edge of the liquid storage cavity (2) is a bottom inner wall (7) of the harbor body (1), and the bottom inner wall (7) is a plane.

3. The port of claim 2, wherein: the harbor body (1) further comprises a bottom outer wall (10) having a cross-sectional profile corresponding to the cross-sectional profile of the bottom inner wall (7).

4. The port of claim 1, wherein: the liquid storage cavity (2) is provided with a first port (8) and a second port (9), the minimum caliber of the first port (8) is larger than the maximum caliber of the second port (9), the injection piece (5) is fixed in the first port (8), and the conduit (4) is communicated with the second port (9).

5. The port of claim 4, wherein: the first port (8) is arranged in an inclined way, the plane of the first port and the plane of the lowest edge are arranged in an included angle (alpha),

0°<α<90°。

6. the port of any one of claims 1 to 5, wherein: the harbor body (1) is provided with an extension pipe (11), and the connecting pipe (3) is sleeved on the periphery of the extension pipe (11) to fix the guide pipe (4) with the extension pipe.

7. The port of claim 6, wherein: the bottom inner wall of the extension pipe (11) is the extension of the bottom inner wall (7) of the harbor body (1).

8. An infusion port comprises

A port body (1);

a reservoir (2) arranged in the port body (1) for containing a medically active substance;

-a connecting tube (3) for fixing the catheter (4) and the port body (1) so as to establish a fluid connection between the reservoir (2) and the catheter (4);

the injection piece (5) is fixedly arranged on the harbor body (1) and is used for puncturing the atraumatic needle (6) and entering the liquid storage cavity (2);

the method is characterized in that: the liquid storage cavity (2) comprises a bottom inner wall (7), the flowing connection between the bottom inner wall (7) and the guide pipe (4) has a height difference h, and h is more than or equal to 0.

9. The port of claim 8, wherein: the bottom inner wall (7) has at least one plane (12).

10. The port of claim 8, wherein: the cross section of the liquid storage cavity (2) is a semi-hollow circle, 3/4 hollow circle, hollow circle or hollow ellipse.

11. The port of claim 8 or 9 or 10, wherein: the liquid storage cavity (2) is provided with a first port (8) and a second port (9), the minimum caliber of the first port (8) is larger than the maximum caliber of the second port (9), the injection piece (5) is fixed in the first port (8), and the conduit (4) is communicated with the second port (9).

12. The port of claim 11, wherein: the first port (8) is arranged in an inclined way, the plane of the first port and the plane of the lowest edge are arranged in an included angle (alpha),

0°<α<90°。

13. the port of claim 8 or 9 or 10, wherein: the harbor body (1) is provided with an extension pipe (11), and the connecting pipe (3) is sleeved on the periphery of the extension pipe (11) to fix the guide pipe (4) with the extension pipe.

14. An infusion port comprises

A port body (1);

a reservoir (2) arranged in the port body (1) for containing a medically active substance;

-a connecting tube (3) for fixing the catheter (4) and the port body (1) so as to establish a fluid connection between the reservoir (2) and the catheter (4);

the injection piece (5) is fixedly arranged on the harbor body (1) and is used for puncturing the atraumatic needle (6) and entering the liquid storage cavity (2);

the method is characterized in that: the harbor body (1) comprises a bottom inner wall (7), wherein a height difference h is formed between the bottom inner wall (7) and the lowest point of the guide pipe (4), and h is more than or equal to 0.

15. The port of claim 14, wherein: the harbor body (1) further comprises a bottom outer wall (10) having a cross-sectional profile corresponding to the cross-sectional profile of the bottom inner wall (7).

16. The port of claim 14, wherein: the bottom inner wall (7) is at least partially planar.

17. The port of claim 14, wherein: the liquid storage cavity (2) is provided with a first port (8) and a second port (9), the minimum caliber of the first port (8) is larger than the maximum caliber of the second port (9), the injection piece (5) is fixed in the first port (8), and the conduit (4) is communicated with the second port (9).

18. The port of claim 17, wherein: the first port (8) is arranged in an inclined way, the plane of the first port and the plane of the lowest edge are arranged in an included angle (alpha),

0°<α<90°。

19. the use method of the transfusion port is characterized in that: comprises the steps of (a) carrying out,

configuring a port, the port comprising

A port body (1);

a reservoir (2) arranged in the port body (1) for containing a medically active substance;

-a connecting tube (3) for fixing the catheter (4) and the port body (1) so as to establish a fluid connection between the reservoir (2) and the catheter (4);

the injection piece (5) is fixedly arranged on the harbor body (1) and is used for puncturing the atraumatic needle (6) and entering the liquid storage cavity (2);

the plane of the lowest edge of the liquid storage cavity (2) is always higher than or equal to the lowest point of the guide pipe (4), and the liquid storage cavity and the guide pipe have a height difference h which is more than or equal to 0;

a non-injury needle (6) is configured, and the needle body of the non-injury needle (6) is linear;

and (3) penetrating the needle body of the atraumatic needle (6) through the injection piece (5) and inserting the atraumatic needle into the liquid storage cavity (2) of the transfusion port.

CN202010466767.9A 2020-05-28 2020-05-28 Infusion port and method of use Pending CN111588941A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010466767.9A CN111588941A (en) 2020-05-28 2020-05-28 Infusion port and method of use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010466767.9A CN111588941A (en) 2020-05-28 2020-05-28 Infusion port and method of use

Publications (1)

Publication Number Publication Date
CN111588941A true CN111588941A (en) 2020-08-28

Family

ID=72181750

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010466767.9A Pending CN111588941A (en) 2020-05-28 2020-05-28 Infusion port and method of use

Country Status (1)

Country Link
CN (1) CN111588941A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4710167A (en) * 1985-05-21 1987-12-01 Applied Precision Limited Implantable device for chronically injecting a substance, in particular a therapeutant
EP0309092A1 (en) * 1987-08-25 1989-03-29 Infusaid, Inc. Implantable device
US5263930A (en) * 1990-03-01 1993-11-23 William D. Ensminger Implantable access devices
US20100063461A1 (en) * 2006-08-03 2010-03-11 Esteve Marc Jose Compact linear implantable site
CN106029124A (en) * 2013-12-19 2016-10-12 美敦力迷你迈德公司 On-body injector and method of use

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4710167A (en) * 1985-05-21 1987-12-01 Applied Precision Limited Implantable device for chronically injecting a substance, in particular a therapeutant
EP0309092A1 (en) * 1987-08-25 1989-03-29 Infusaid, Inc. Implantable device
US5263930A (en) * 1990-03-01 1993-11-23 William D. Ensminger Implantable access devices
US20100063461A1 (en) * 2006-08-03 2010-03-11 Esteve Marc Jose Compact linear implantable site
CN106029124A (en) * 2013-12-19 2016-10-12 美敦力迷你迈德公司 On-body injector and method of use

Similar Documents

Publication Publication Date Title
US5620419A (en) 1997-04-15 Port stabilizer ring
CA1306916C (en) 1992-09-01 Dual access infusion and monitoring system
US5997524A (en) 1999-12-07 Catheter assembly for percutaneous access to subcutaneous port
EP2320979B1 (en) 2020-12-02 Conical diffuser tip
CN111588940A (en) 2020-08-28 Implanted infusion port and using method
CN212651171U (en) 2021-03-05 Implanted transfusion port
US20170128709A1 (en) 2017-05-11 Venous Access Implantable Port
CN212651172U (en) 2021-03-05 Transfusion port
WO1996029112A1 (en) 1996-09-26 Vascular access system
CN112791267B (en) 2024-12-17 An infusion port
CN111588941A (en) 2020-08-28 Infusion port and method of use
CN215460909U (en) 2022-01-11 Implantable drug delivery device
CN108785791B (en) 2020-12-18 Double-lumen venous transfusion port capable of preventing thrombosis and preventing secondary infection
WO2023181979A1 (en) 2023-09-28 Therapeutic device for brain diseases, connector for therapeutic devices, and connector fixing tool for therapeutic devices
CN113599620A (en) 2021-11-05 Implantable drug delivery device
CN217286741U (en) 2022-08-26 Medical implantable drug delivery device
CN203154560U (en) 2013-08-28 Biatrial catheter
CN216366290U (en) 2022-04-26 Implantable drug delivery device
CN216366291U (en) 2022-04-26 Vortex type implanted drug delivery device and infusion device
CN218458411U (en) 2023-02-10 Implantable drug delivery device
CN221600887U (en) 2024-08-27 Oncology device of dosing
CN222510590U (en) 2025-02-21 Circulating transfusion port
CN217793261U (en) 2022-11-15 Continuous drug administration device in superficial solid tumor
JPS63296770A (en) 1988-12-02 Subcutaneous embedding type reservoir
CN216366156U (en) 2022-04-26 Transfusion needle connecting mechanism and butterfly wing needle

Legal Events

Date Code Title Description
2020-08-28 PB01 Publication
2020-08-28 PB01 Publication
2020-09-22 SE01 Entry into force of request for substantive examination
2020-09-22 SE01 Entry into force of request for substantive examination
2024-09-10 RJ01 Rejection of invention patent application after publication

Application publication date: 20200828

2024-09-10 RJ01 Rejection of invention patent application after publication